Enanta Pharmaceuticals, Inc. (ENTA) has 20 known insider and institutional holders on record. The largest holder is Luly Jay R. with 862,826 shares. Other notable holders include Goldberg Marc E. and SCHUHSLER HELMUT.
Over the last 12 months, insiders have made 38 transactions in ENTA stock — 20 buys (valued at $13.03M) and 9 sells (valued at $183.17K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
ENTA Insider Ownership
Top Holder
Luly Jay R.
862,826 shares
Buys (12 mo)
20
$13.03M value
Sells (12 mo)
9
$183.17K value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Luly Jay R. |
President and CEO |
862,826 |
2026-02-13 |
|
| 2 |
Goldberg Marc E. |
Director |
547,606 |
2013-12-06 |
|
| 3 |
Schuhsler Helmut |
10 Percent Owner |
388,617 |
2014-02-25 |
|
| 4 |
Or Yat Sun |
Chief Scientific Officer |
373,042 |
2026-02-13 |
|
| 5 |
Tvm V Life Science Ventures Gmbh & Co Kg |
10 Percent Owner |
343,505 |
2014-03-07 |
|
| 6 |
Mellett Paul J |
Chief Fin. & Admin Officer |
95,884 |
2025-02-14 |
|
| 7 |
Gardiner Nathaniel S. |
Chief Legal Officer |
75,688 |
2024-02-27 |
|
| 8 |
Luu Brendan |
Chief Business Officer |
39,904 |
2026-02-13 |
|
| 9 |
Kieffer Tara Lynn |
Chief Product Strategy Officer |
32,195 |
2026-02-13 |
|
| 10 |
Rottinghaus Scott T. |
Chief Medical Officer |
23,442 |
2026-02-13 |
|
| 11 |
Foletta Mark G |
Director |
20,000 |
2026-03-13 |
|
| 12 |
Russell Lesley |
Director |
20,000 |
2026-03-13 |
|
| 13 |
Carter Bruce L A |
Director |
20,000 |
2026-03-13 |
|
| 14 |
Vance Terry |
Director |
20,000 |
2026-03-13 |
|
| 15 |
Hata Yujiro S |
Director |
20,000 |
2026-03-13 |
|
| 16 |
Peterson Kristine |
Director |
20,000 |
2026-03-13 |
|
| 17 |
Saints Capital Granite, L.p. |
10 Percent Owner |
17,207 |
2013-10-16 |
|
| 18 |
Trout Harry R. Iii |
See Remarks |
16,348 |
2025-12-05 |
|
| 19 |
Adda Nathalie |
Sr. VP & Chief Medical Officer |
12,481 |
2022-03-03 |
|
| 20 |
Ocain Tim |
Senior Vice President |
12,127 |
2019-02-13 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-11 |
Hata Yujiro S |
Director |
RSU Award |
20,000 |
$14.17 |
$283.4K |
| 2026-03-11 |
Vance Terry |
Director |
RSU Award |
20,000 |
$14.17 |
$283.4K |
| 2026-03-11 |
Peterson Kristine |
Director |
RSU Award |
20,000 |
$14.17 |
$283.4K |
| 2026-03-11 |
Russell Lesley |
Director |
RSU Award |
20,000 |
$14.17 |
$283.4K |
| 2026-03-11 |
Foletta Mark G |
Director |
RSU Award |
20,000 |
$14.17 |
$283.4K |
| 2026-03-11 |
Carter Bruce L A |
Director |
RSU Award |
20,000 |
$14.17 |
$283.4K |
| 2026-02-12 |
Rottinghaus Scott T. |
Chief Medical Officer |
RSU Award |
1,650 |
- |
- |
| 2026-02-12 |
Luu Brendan |
Chief Business Officer |
RSU Award |
1,575 |
- |
- |
| 2026-02-12 |
Kieffer Tara Lynn |
Chief Product Strategy Officer |
RSU Award |
1,575 |
- |
- |
| 2026-02-12 |
Kowalsky Matthew Paul |
Chief Legal Officer |
RSU Award |
1,318 |
- |
- |
| 2026-02-12 |
Or Yat Sun |
Chief Scientific Officer |
RSU Award |
1,650 |
- |
- |
| 2026-02-12 |
Luly Jay R. |
President and CEO |
RSU Award |
4,800 |
- |
- |
| 2025-12-05 |
Capps Kathleen S. |
See Remarks |
Informative Sell |
323 |
$14.23 |
$4.6K |
| 2025-12-05 |
Trout Harry R. Iii |
See Remarks |
Informative Sell |
542 |
$14.23 |
$7.71K |
| 2025-12-05 |
Rottinghaus Scott T. |
Chief Medical Officer |
Informative Sell |
798 |
$14.23 |
$11.36K |
| 2025-12-05 |
Luu Brendan |
Chief Business Officer |
Informative Sell |
1,394 |
$14.23 |
$19.84K |
| 2025-12-05 |
Kieffer Tara Lynn |
Chief Product Strategy Officer |
Informative Sell |
2,106 |
$14.23 |
$29.97K |
| 2025-12-05 |
Or Yat Sun |
Chief Scientific Officer |
Informative Sell |
2,390 |
$14.23 |
$34.01K |
| 2025-12-05 |
Luly Jay R. |
President and CEO |
Informative Sell |
4,743 |
$14.23 |
$67.49K |
| 2025-12-02 |
Capps Kathleen S. |
See Remarks |
Informative Sell |
207 |
$13.96 |
$2.89K |
| 2025-12-01 |
Capps Kathleen S. |
See Remarks |
Tax Withholding of RSU |
85 |
$14.12 |
$1.2K |
| 2025-12-02 |
Trout Harry R. Iii |
See Remarks |
Informative Sell |
380 |
$13.96 |
$5.3K |
| 2025-12-01 |
Trout Harry R. Iii |
See Remarks |
Tax Withholding of RSU |
105 |
$14.12 |
$1.48K |
| 2025-12-01 |
Luu Brendan |
Chief Business Officer |
Tax Withholding of RSU |
498 |
$14.12 |
$7.03K |
| 2025-12-01 |
Kieffer Tara Lynn |
Chief Product Strategy Officer |
Tax Withholding of RSU |
753 |
$14.12 |
$10.63K |
